18
5
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T30142 |
ARRY-403
AMG-151,ARRY 403,ARRY403,ARRY-403,AMG151,AMG 151 |
Glucokinase | Metabolism |
ARRY-403 是一种新型葡萄糖激酶激活剂,可降低 2 型糖尿病患者的空腹和餐后血糖,可用于治疗糖尿病。 | |||
T83969 |
Casein
|
Hydroxylase | Metabolism |
Casein 是一种具有多种作用的牛奶蛋白,参与新型药物递送系统,通过其胃内凝血特性以不同的方式影响餐后氨基酸递送。 | |||
T16083 |
Mizagliflozin
GSK-1614235 free base,KGA-3235 free base,DSP-3235 free base |
SGLT | GPCR/G Protein |
Mizagliflozin (GSK-1614235 free base) 是口服有效的、选择性的 SGLT1抑制剂,对人 SGLT1 的 Ki 值为 27 nM。Mizagliflozin 对 SGLT1 的选择性是 SGLT2的303 倍。它是抗糖尿病药物,可以改善餐后血糖波动。它在改善慢性便秘方面具有潜在的作用。 | |||
T30118 |
Arbaclofen placarbil
XP 19986,XP19986,XP-19986 |
Others | Others |
Arbaclofen placarbil( XP19986) is a GABA(B) receptor agonist.Arbaclofen Placarbil is a novel R-baclofen prodrug with improved absorption, distribution, metabolism, and elimination properties compared to R-baclofen. And it can reduce postprandial reflux in | |||
T6203L |
Saxagliptin hydrochloride
BMS477118,Saxagliptin,BMS 477118,Saxagliptin HCl,BMS-477118 |
Others | Others |
Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose conce | |||
T29154 |
WB403
WB-403,WB 403 |
Others | Others |
WB403 is a TGR5 activator. WB403 significantly decreases fasting blood glucose, postprandial blood glucose and HbA1c, improves glucose tolerance in type 2 diabetic mice. WB403 increases pancreatic β-cells and restores the normal distribution pattern of α- | |||
T29448 |
50F10
50 F 10,50-F-10 |
Others | Others |
50F10 is a stabilizer for the active LPL dimer. It can act by preventing angptl4- and heat-induced inactivation of LPL and reducing postprandial triglyceride levels. | |||
T25375 |
Enprostil
RS-84135,RS 84135,Gardrin,RS84135 |
Others | Others |
Enprostil is a synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has efficient and safe in the therapy of gastroduodenal ulcers. | |||
TP1566 |
GIP (1-30) amide (Human) (TFA)
|
||
GIP (1-30) amide (Human) TFA is a glucose-dependent insulinotropic polypeptide fragment. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions. | |||
T26718 |
AZD6370
AZD-6370,AZD 6370 |
Others | Others |
AZD-6370 is a glucokinase activator. AZD-6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food. AZD-6370 do not affect the central counterregulatory response to hypoglycemia | |||
T14382 |
AZD7687
|
Others | Others |
AZD7687 is a potent and selective DGAT1 inhibitor with an IC50 value of 80 nM (hDGAT1). IC50 value: 80 nM [1] Target: DGAT1 in vitro: Plasma AZD7687 exposure was measured repeatedly. AZD7687 markedly reduced postprandial TAG excursion with a steep concent | |||
T71340 |
Mizagliflozin sebacate
|
Others | Others |
Mizagliflozin sebacate is a sodium-glucose transporter inhibitor. It is expected to improve postprandial hyperglycemia by suppressing glucose absorption from the intestine with a novel mechanism of action different from that of conventional alpha-glucosidase inhibitors. Mizagliflozin blocks intestinal glucose absorption and reduce GIP secretion in rats and humans, suggesting SGLT1 glucose transport is critical for GIP release. | |||
T35798 |
Massarigenin C
|
Others | Others |
Massarigenin C is a fungal metabolite that has been found inM. flavoroseaand has enzyme inhibitory activities.1,2Massarigenin C inhibits neuraminidasein vitro(IC50= 4.15 μM).2It is also an inhibitor of yeast α-glucosidase (IC50= 1.25 mM).1It reduces the postprandial peak in blood glucose levels in an oral sucrose tolerance test in normo- and hyperglycemic mice when administered at doses of 3.2, 10, and 31.6 mg/kg. | |||
T82923 |
Bamadutide
SAR425899 |
||
Bamadutide (SAR425899)是一种高效的GLP-1/GIP受体激动剂,主要通过增强β细胞功能和降低葡萄糖吸收速率,从而改善餐后血糖控制。该化合物适用于2型糖尿病的研究。 | |||
T68471 |
(+/-)- Adomeglivant
|
Others | Others |
(+/-)- Adomeglivant, also known as LY2409021, is a potent and selective glucagon receptor antagonist. LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Blockade of glucagon signalling in patients with type 2 diabetes is well tolerated and results in substantial reduction of fasting and postprandial glucose with minimal hypoglycaemia, but with reversible increases in aminotransferases. Inhibition of glucagon signalling by LY2409021 is a promising potential treatm... | |||
T72909 |
D-(+)-Sorbose
|
Others | Others |
D-(+)-Sorbose,一种 D-Sorbose 的活性对映异构体,可抑制双糖酶活性并对大鼠餐后血糖和胰岛素水平有抑制作用。D-Sorbose 作为甜味剂有助于预防相关疾病,如 2 型糖尿病。 | |||
T76041 |
GIP (1-30) amide,human acetate
|
||
GIP (1-30) amide, human acetate 为葡萄糖依赖性促胰岛素多肽(GIP)的片段,作为一种肠降血糖素激素,它能在10^-9至10^-6M的剂量范围内,依赖剂量地促进胰岛素的分泌,并有效减缓餐后血糖波动。 | |||
T37522 |
Teneligliptin
|
Others | Others |
Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM. Teneligliptin (MP-513) inhibits all these DPP-4 enzymes in a concentration-dependent manner. The IC50s of Teneligliptin (MP-513) for rhDPP-4, human plasma, and rat plasma are 0.889, 1.75, and 1.35 nM, respectively. A study of enzyme inhibition kinetics is conducted for Teneligliptin (M... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3675 |
1-Deoxynojirimycin
Duvoglustat,Moranoline,1-脱氧野尻霉素,moranolin |
PI3K; Glucosidase | Metabolism; PI3K/Akt/mTOR signaling |
1-Deoxynojirimycin (Moranoline) 是一种口服具有活性的 α-葡萄糖苷酶抑制剂。它具有降血糖、减肥和抗病毒的活性。它抑制餐后血糖,预防糖尿病。 | |||
T21344 |
1-Deoxynojirimycin hydrochloride
Moranoline,去氧野艽霉素盐酸盐,AT2220,Duvoglustat hydrochloride,1-Deoxynojirimycin,DNJ,deoxynojirimycin |
PI3K; Antibacterial; Antibiotic; Glucosidase | Metabolism; Microbiology/Virology; PI3K/Akt/mTOR signaling |
1-Deoxynojirimycin hydrochloride (Moranoline) 是一种口服有效的 α-葡萄糖苷酶抑制剂,具有降血糖、减肥和抗病毒的作用,可抑制餐后血糖,预防糖尿病。 | |||
TJS0387 |
Desoxyrhaponticin
去氧土大黄苷,Deoxyrhapontin,脱氧土大黄苷,Deoxyrhaponticin |
Apoptosis; Fatty Acid Synthase | Apoptosis; Metabolism |
Desoxyrhaponticin (Deoxyrhaponticin) 是来自西藏营养食品唐古特大黄中的一种二苯乙烯苷。它是脂肪酸合成酶抑制剂,抑制细胞内 FAS 活性,下调人乳腺癌 MCF-7细胞中 FAS 的表达。它是控制糖尿病餐后高血糖的潜在药物。 | |||
T2S0731 |
Trilobatin
三叶苷,三叶甙,P-Phlorizin |
Amylase | Metabolism |
Trilobatin (P-Phlorizin) 是源自Lithocarpus polystachyusRehd 的甜味剂,是一种HIV-1抑制剂,靶向 Gp41 包膜蛋白,具有神经保护作用。它还是SGLT1/2抑制剂,可选择性诱导人肝母细胞瘤细胞增殖。 | |||
T80007 |
Stevisalioside A
|
Phosphatase | Metabolism |
Stevisalioside A (Compound 2),一种从甜叶菊根提取的化合物,展现出抗糖尿病的口服活性。该化合物有效抑制PTP1B,IC50为526.8 μM,并能降低Stevisalioside A引起的高血糖小鼠血糖水平,改善餐后血糖峰值及口服葡萄糖和胰岛素耐量测试结果。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02622 |
Aldolase B Protein, Human, Recombinant (GST)
aldolase B, fructose-bisphosphate,ALDO2,ALDB |
Human | E. coli |
The aldolase family members involved in metabolism and glycolysis are present in three isoforms: ALDOA, ALDOB, and ALDOC. Aldolases are differentially expressed in human tissues, and aberrant expression has been observed in several human diseases and cancer types. Via GATA6, metastatic cells in the liver upregulate the enzyme aldolase B (ALDOB), which enhances fructose metabolism and provides fuel for major pathways of central carbon metabolism during tumor cell proliferation. Targeting ALDOB or... |